$0.902
-0.045 (-5.02%)Al cierre
Noticias de DH
Eventos de DH
Definitive Healthcare Appoints Clay Ritchey as New CEO
Definitive Healthcare announced that its board of directors has appointed Clay Ritchey as the company's next CEO and as a member of the board of directors, each effective September 8. Ritchey succeeds Kevin Coop, who departed as CEO and as a member of the board of directors, effective August 31. Coop had served as CEO since June 2024. Ritchey joins Definitive Healthcare after most recently serving as CEO of Verato.
Consensus 18c Narrows FY26 Revenue Outlook to $220M
Consensus 18c. Narrows FY26 revenue view to $220M from $220M-$226M, consensus $223.45M. Sees FY26 adjusted EBITDA view $57M-$59M.
Definitive Healthcare Q2 Revenue at $55.2M
Reports Q2 revenue $55.2M, consensus $55.39M. "Definitive Healthcare delivered another quarter in line with or above our guidance ranges, reflecting continued discipline alongside targeted investment in our growth priorities," said Kevin Coop, CEO of Definitive Healthcare. "We're encouraged by our second consecutive quarter of year-over-year improvement in net dollar retention, strong win-back momentum across our end markets, and the launch of Turbo, our new AI-powered healthcare intelligence platform, which marks a significant milestone in our innovation strategy. We remain confident that our focus on data quality and customer success is the right path to return to sustained, predictable growth, while continuing to generate strong profitability and cash flow."
Sees Q3 Revenue of $54M-$55M
Sees Q3 revenue $54M-$55M, consensus $55.38M. Sees Q3 adjusted EBITDA $13.5M-$14.5M.
Company Confirms FY26 Revenue Outlook of $220M to $226M
Consensus 17c. Backs FY26 revenue view $220M-$226M, consensus $223.64M. Backs FY26 adjusted EBITDA view $13.5M-$14.5M.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.